These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

639 related articles for article (PubMed ID: 33427604)

  • 1. The human papillomavirus oncoproteins: a review of the host pathways targeted on the road to transformation.
    Scarth JA; Patterson MR; Morgan EL; Macdonald A
    J Gen Virol; 2021 Mar; 102(3):. PubMed ID: 33427604
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human Papillomaviruses-Associated Cancers: An Update of Current Knowledge.
    Pešut E; Đukić A; Lulić L; Skelin J; Šimić I; Milutin Gašperov N; Tomaić V; Sabol I; Grce M
    Viruses; 2021 Nov; 13(11):. PubMed ID: 34835040
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human papillomavirus E6 and E7 oncoproteins as risk factors for tumorigenesis.
    Ganguly N; Parihar SP
    J Biosci; 2009 Mar; 34(1):113-23. PubMed ID: 19430123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of apoptosis by human papillomavirus (HPV) oncoproteins.
    Garnett TO; Duerksen-Hughes PJ
    Arch Virol; 2006 Dec; 151(12):2321-35. PubMed ID: 16862386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Manipulation of JAK/STAT Signalling by High-Risk HPVs: Potential Therapeutic Targets for HPV-Associated Malignancies.
    Morgan EL; Macdonald A
    Viruses; 2020 Sep; 12(9):. PubMed ID: 32899142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteasomal degradation of p130 facilitate cell cycle deregulation and impairment of cellular differentiation in high-risk Human Papillomavirus 16 and 18 E7 transfected cells.
    Gandhi S; Nor Rashid N; Mohamad Razif MF; Othman S
    Mol Biol Rep; 2021 Jun; 48(6):5121-5133. PubMed ID: 34169395
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PDZ Domain-Containing Protein NHERF-2 Is a Novel Target of Human Papillomavirus 16 (HPV-16) and HPV-18.
    Saidu NEB; Filić V; Thomas M; Sarabia-Vega V; Đukić A; Miljković F; Banks L; Tomaić V
    J Virol; 2019 Dec; 94(1):. PubMed ID: 31597772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular mechanisms underlying human papillomavirus E6 and E7 oncoprotein-induced cell transformation.
    Mittal S; Banks L
    Mutat Res Rev Mutat Res; 2017; 772():23-35. PubMed ID: 28528687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cellular transformation by human papillomaviruses: lessons learned by comparing high- and low-risk viruses.
    Klingelhutz AJ; Roman A
    Virology; 2012 Mar; 424(2):77-98. PubMed ID: 22284986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The human papillomavirus family and its role in carcinogenesis.
    Tommasino M
    Semin Cancer Biol; 2014 Jun; 26():13-21. PubMed ID: 24316445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel Functions of the Human Papillomavirus E6 Oncoproteins.
    Wallace NA; Galloway DA
    Annu Rev Virol; 2015 Nov; 2(1):403-23. PubMed ID: 26958922
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-Risk Alphapapillomavirus Oncogenes Impair the Homologous Recombination Pathway.
    Wallace NA; Khanal S; Robinson KL; Wendel SO; Messer JJ; Galloway DA
    J Virol; 2017 Oct; 91(20):. PubMed ID: 28768872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular interactions of 'high risk' human papillomaviruses E6 and E7 oncoproteins: implications for tumour progression.
    Chakrabarti O; Krishna S
    J Biosci; 2003 Apr; 28(3):337-48. PubMed ID: 12734411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spatial and Functional Organization of Human Papillomavirus Replication Foci in the Productive Stage of Infection.
    Khurana S; Markowitz TE; Kabat J; McBride AA
    mBio; 2021 Dec; 12(6):e0268421. PubMed ID: 34749533
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Role of E6 Spliced Isoforms (E6*) in Human Papillomavirus-Induced Carcinogenesis.
    Olmedo-Nieva L; Muñoz-Bello JO; Contreras-Paredes A; Lizano M
    Viruses; 2018 Jan; 10(1):. PubMed ID: 29346309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Human Papillomavirus E6 PDZ Binding Motif: From Life Cycle to Malignancy.
    Ganti K; Broniarczyk J; Manoubi W; Massimi P; Mittal S; Pim D; Szalmas A; Thatte J; Thomas M; Tomaić V; Banks L
    Viruses; 2015 Jul; 7(7):3530-51. PubMed ID: 26147797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human papillomavirus type 18 E5 oncoprotein cooperates with E6 and E7 in promoting cell viability and invasion and in modulating the cellular redox state.
    Hochmann J; Parietti F; Martínez J; Lopez AC; Carreño M; Quijano C; Boccardo E; Sichero L; Möller MN; Mirazo S; Arbiza J
    Mem Inst Oswaldo Cruz; 2020; 115():e190405. PubMed ID: 32187327
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human papillomavirus immortalization and transformation functions.
    Münger K; Howley PM
    Virus Res; 2002 Nov; 89(2):213-28. PubMed ID: 12445661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human Papillomaviruses as Infectious Agents in Gynecological Cancers. Oncogenic Properties of Viral Proteins.
    Haręża DA; Wilczyński JR; Paradowska E
    Int J Mol Sci; 2022 Feb; 23(3):. PubMed ID: 35163748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human Papillomavirus E7 Oncoprotein Subverts Host Innate Immunity via SUV39H1-Mediated Epigenetic Silencing of Immune Sensor Genes.
    Lo Cigno I; Calati F; Borgogna C; Zevini A; Albertini S; Martuscelli L; De Andrea M; Hiscott J; Landolfo S; Gariglio M
    J Virol; 2020 Jan; 94(4):. PubMed ID: 31776268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.